Etiopathology and neurobiology of obsessive-compulsive disorder: focus on biological rhythms and chronotherapy

References

• Masellis M, Rector NA, Richter MA. Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity. Can J Psychiatry. 2003;48(2):72–77.
   Web of Science ®Google Scholar
• Koran LM, Thienemann ML, Davenport R. Quality of life for patients with obsessive-compulsive disorder. Am J Psychiatry. 1996;153(6):783–788.
   PubMed Web of Science ®Google Scholar
• Eisen JL, Mancebo MA, Pinto A, et al. Impact of obsessive- compulsive disorder on quality of life. Compr Psychiatry. 2006;47(4):270–275.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
   Google Scholar
• Murray CJ, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press; 1996.
   Google Scholar
• Stein DJ, Fineberg NA, Bienvenu OJ, et al. Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety. 2010;27(6):495–506.
   PubMed Web of Science ®Google Scholar
• Monteleone P, Catapano F, Del Buono G, Maj M. Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder. Acta Psychiatr Scand. 1994;89(6):411–415.
   PubMed Web of Science ®Google Scholar
• Catapano F, Monteleone P, Fuschino A, Maj M, Kemali D. Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder. Psychiatry Res. 1992;44(3):217–225.
   PubMed Web of Science ®Google Scholar
• Millet B, Touitou Y, Poirier MF, et al. Plasma melatonin and cortisol in patients with obsessive-compulsive disorder: relationship with axillary temperature, physical activity, and clinical symptoms. Biol Psychiatry. 1998;44(9):874–881.
   Web of Science ®Google Scholar
• Gehris TL, Kathol RG, Black DW, Noyes R Jr. Urinary free cortisol levels in obsessive-compulsive disorder. Psychiatry Res. 1990;32(2):151–158.
   Web of Science ®Google Scholar
• Bigos KL, Folan MM, Jones MR, Haas GL, Kroboth FJ, Kroboth PD. Dysregulation of neurosteroids in obsessive compulsive disorder. J Psychiatr Res. 2009;43(4):442–445.
   PubMed Web of Science ®Google Scholar
• Gustafsson PE, Gustafsson PA, Ivarsson T, Nelson N. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder. Neuropsychobiology. 2008;57(1–2):14–21.
   Web of Science ®Google Scholar
• Veldhuis JD, Johnson ML. Operating characteristics of the hypothalamo-pituitary-gonadal axis in men: circadian, ultradian, and pulsatile release of prolactin and its temporal coupling with luteinizing hormone. J Clin Endocrinol Metab. 1988;67(1):116–123.
   Web of Science ®Google Scholar
• Cox RC, Olatunji BO. Sleep disturbance and obsessive-compulsive symptoms: results from the national comorbidity survey replication. J Psychiatr Res. 2016;75:41–45.
   Web of Science ®Google Scholar
• Paterson JL, Reynolds AC, Ferguson SA, Dawson D. Sleep and obsessive-compulsive disorder (OCD). Sleep Med Rev. 2013;17(6):465–474.
   PubMed Web of Science ®Google Scholar
• Timpano KR, Carbonella JY, Bernert RA, Schmidt NB. Obsessive compulsive symptoms and sleep difficulties: exploring the unique relationship between insomnia and obsessions. J Psychiatr Res. 2014;57:101–107.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Fineberg NA, Drummond LM, et al. Delayed sleep phase in severe obsessive-compulsive disorder: a systematic case-report survey. CNS Spectr. 2008;13(5):406–413.
   PubMed Web of Science ®Google Scholar
• Turner J, Drummond LM, Mukhopadhyay S, et al. A prospective study of delayed sleep phase syndrome in patients with severe resistant obsessive-compulsive disorder. World Psychiatry. 2007;6(2):108–111.
   PubMed Web of Science ®Google Scholar
• Drummond LM, Wulff K, Rani RS, et al. How should we measure delayed sleep phase shift in severe, refractory obsessive-compulsive disorder? Int J Psychiatry Clin Pract. 2012;16(4):268–276.
   PubMed Web of Science ®Google Scholar
• Lack LC, Wright HR, Bootzin RR. Delayed sleep-phase disorder. Sleep Med Clin. 2009;4(2):229–239.
   Google Scholar
• Coles ME, Schubert JR, Sharkey KM. Delayed bedtimes and obsessive-compulsive symptoms. Behav Sleep Med. 2012;10(4):258–265.
   PubMed Web of Science ®Google Scholar
• Schubert JR, Coles ME. Obsessive-compulsive symptoms and characteristics in individuals with delayed sleep phase disorder. J Nerv Ment Dis. 2013;201(10):877–884.
   PubMed Web of Science ®Google Scholar
• Minkel J, Moreta M, Muto J, et al. Sleep deprivation potentiates HPA axis stress reactivity in healthy adults. Health Psychol. 2014;33(11):1430–1434.
   PubMed Web of Science ®Google Scholar
• Babson KA, Trainor CD, Feldner MT, Blumenthal H. A test of the effects of acute sleep deprivation on general and specific self-reported anxiety and depressive symptoms: an experimental extension. J Behav Ther Exp Psychiatry. 2010;41(3):297–303.
   PubMed Web of Science ®Google Scholar
• Dunn J, Scheving L, Millet P. Circadian variation in stress-evoked increases in plasma corticosterone. Am J Physiol. 1972;223(2):402–406.
   Google Scholar
• Kant GJ, Mougey EH, Meyerhoff JL. Diurnal variation in neuroendocrine response to stress in rats: plasma ACTH, beta-endorphin, beta-LPH, corticosterone, prolactin and pituitary cyclic AMP responses. Neuroendocrinology. 1986;43(3):383–390.
   Web of Science ®Google Scholar
• Janet P. Les obsessions et la psychasthenie [Obsessions and Psychasthenia]. Paris: Bailliere; 1908. French.
   Google Scholar
• Millet B, Touitou Y, Poirier MF, et al. Obsessive-compulsive disorder: evaluation of clinical and biological circadian parameters during fluoxetine treatment. Psychopharmacology. 1999;146(3):268–274.
   Web of Science ®Google Scholar
• Herman S, Koran LM. In vivo measurement of obsessive-compulsive disorder symptoms using palmtop computers. Comput Hum Behav. 1998;14(3):449–462.
   Web of Science ®Google Scholar
• Nota JA, Gibb BE, Coles ME. Obsessions and time of day: a self-monitoring study in individuals with obsessive-compulsive disorder. J Cogn Psychother. 2014;28(2):134–144.
   Google Scholar
• Rachman S. A cognitive theory of compulsive checking. Behav Res Ther. 2002;40(6):625–639.
   PubMed Web of Science ®Google Scholar
• Coles ME, Sharkey KM. Compulsion or chronobiology? A case of severe obsessive-compulsive disorder treated with cognitive-behavioral therapy augmented with chronotherapy. J Clin Sleep Med. 2011;7(3):307–309.
   PubMed Web of Science ®Google Scholar
• Cameron OG, Lee MA, Kotun J, McPhee KM. Circadian symptom fluctuations in people with anxiety disorders. J Affect Disord. 1986;11(3):213–218.
   Web of Science ®Google Scholar
• Harkin B, Kessler K. The role of working memory in compulsive checking and OCD: a systematic classification of 58 experimental findings. Clin Psychol Rev. 2011;31(6):1004–1021.
   PubMed Web of Science ®Google Scholar
• Harrison Y, Jones K, Waterhouse J. The influence of time awake and circadian rhythm upon performance on a frontal lobe task. Neuropsychologia. 2007;45(8):1966–1972.
   PubMed Web of Science ®Google Scholar
• Wright KP Jr, Hull JT, Czeisler CA. Relationship between alertness, performance, and body temperature in humans. Am J Physiol Regul Integr Comp Physiol. 2002;283(6):R1370–R1377.
   PubMed Web of Science ®Google Scholar
• de Vries FE, de Wit SJ, Cath DC, et al. Compensatory frontoparietal activity during working memory: an endophenotype of obsessive-compulsive disorder. Biol Psychiatry. 2014;76(11):878–887.
   PubMed Web of Science ®Google Scholar
• Vandewalle G, Archer SN, Wuillaume C, et al. Functional magnetic resonance imaging-assessed brain responses during an executive task depend on interaction of sleep homeostasis, circadian phase, and PER3 genotype. J Neurosci. 2009;29(25):7948–7956.
   PubMed Web of Science ®Google Scholar
• Insel TR, Murphy DL. The psychopharmacological treatment of obsessive-compulsive disorder: a review. J Clin Psychopharmacol. 1981;1(5):304–311.
   Web of Science ®Google Scholar
• Hesse S, Muller U, Lincke T, et al. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res. 2005;140(1):63–72.
   PubMed Web of Science ®Google Scholar
• Pogarell O, Hamann C, Popperl G, et al. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry. 2003;54(12):1406–1413.
   PubMed Web of Science ®Google Scholar
• Hollander E, DeCaria C, Nitescu A, et al. Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Res. 1991;37(2):161–177.
   Web of Science ®Google Scholar
• Hollander E, DeCaria CM, Nitescu A, et al. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry. 1992;49(1):21–28.
   PubMed Web of Science ®Google Scholar
• Roman V, Walstra I, Luiten PG, Meerlo P. Too little sleep gradually desensitizes the serotonin 1A receptor system. Sleep. 2005;28(12):1505–1510.
   PubMed Web of Science ®Google Scholar
• Piras F, Piras F, Chiapponi C, Girardi P, Caltagirone C, Spalletta G. Widespread structural brain changes in OCD: a systematic review of voxel-based morphometry studies. Cortex. 2015;62:89–108.
   PubMed Web of Science ®Google Scholar
• Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1987;44(3):211–218.
   Web of Science ®Google Scholar
• Swedo SE, Schapiro MB, Grady CL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 1989;46(6):518–523.
   Web of Science ®Google Scholar
• Machlin SR, Harris GJ, Pearlson GD, Hoehn-Saric R, Jeffery P, Camargo EE. Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. Am J Psychiatry. 1991;148(9):1240–1242.
   PubMed Web of Science ®Google Scholar
• Rauch SL, Jenike MA, Alpert NM, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry. 1994;51(1):62–70.
   Web of Science ®Google Scholar
• Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res. 2004;132(1):69–79.
   PubMed Web of Science ®Google Scholar
• Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32(3):525–549.
   PubMed Web of Science ®Google Scholar
• Maia TV, Cooney RE, Peterson BS. The neural bases of obsessive-compulsive disorder in children and adults. Dev Psychopathol. 2008;20(4):1251–1283.
   PubMed Web of Science ®Google Scholar
• Via E, Cardoner N, Pujol J, et al. Amygdala activation and symptom dimensions in obsessive-compulsive disorder. Br J Psychiatry. 2014;204(1):61–68.
   Web of Science ®Google Scholar
• Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(35):26–37.
   Google Scholar
• Nakao T, Okada K, Kanba S. Neurobiological model of obsessive-compulsive disorder: evidence from recent neuropsychological and neuroimaging findings. Psychiatry Clin Neurosci. 2014;68(8):587–605.
   PubMed Web of Science ®Google Scholar
• Simon D, Adler N, Kaufmann C, Kathmann N. Amygdala hyperactivation during symptom provocation in obsessive-compulsive disorder and its modulation by distraction. Neuroimage Clin. 2014;4:549–557.
   Web of Science ®Google Scholar
• Jenike MA, Baer L, Minichiello M, editors. Obsessive-Compulsive Disorders: Practical Management. St Louis, MO: Mosby; 1998.
   Google Scholar
• Figee M, Vink M, de Geus F, et al. Dysfunctional reward circuitry in obsessive-compulsive disorder. Biol Psychiatry. 2011;69(9):867–874.
   PubMed Web of Science ®Google Scholar
• Jung WH, Kang DH, Han JY, et al. Aberrant ventral striatal responses during incentive processing in unmedicated patients with obsessive-compulsive disorder. Acta Psychiatr Scand. 2011;123(5):376–386.
   Web of Science ®Google Scholar
• Murray G, Nicholas CL, Kleiman J, et al. Nature’s clocks and human mood: the circadian system modulates reward motivation. Emotion. 2009;9(5):705–716.
   PubMed Web of Science ®Google Scholar
• Hasler BP, Mehl MR, Bootzin RR, Vazire S. Preliminary evidence of diurnal rhythms in everyday behaviors associated with positive affect. J Res Pers. 2008;42(6):1537–1546.
   Web of Science ®Google Scholar
• Sleipness EP, Sorg BA, Jansen HT. Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: dependence on the suprachiasmatic nucleus. Brain Res. 2007;1129(1):34–42.
   PubMed Web of Science ®Google Scholar
• Albrecht U. The circadian clock, reward, and memory. Front Mol Neurosci. 2011;4:41.
   Web of Science ®Google Scholar
• Hasler BP, Clark DB. Circadian misalignment, reward-related brain function, and adolescent alcohol involvement. Alcohol Clin Exp Res. 2013;37(4):558–565.
   PubMed Web of Science ®Google Scholar
• Karatsoreos IN, Bhagat S, Bloss EB, Morrison JH, McEwen BS. Disruption of circadian clocks has ramifications for metabolism, brain, and behavior. Proc Natl Acad Sci U S A. 2011;108(4):1657–1662.
   PubMed Web of Science ®Google Scholar
• Wu JC, Gillin JC, Buchsbaum MS, et al. Frontal lobe metabolic decreases with sleep deprivation not totally reversed by recovery sleep. Neuropsychopharmacology. 2006;31(12):2783–2792.
   Web of Science ®Google Scholar
• Goel N, Rao H, Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2009;29(4):320–339.
   PubMed Web of Science ®Google Scholar
• St-Onge MP, McReynolds A, Trivedi ZB, Roberts AL, Sy M, Hirsch J. Sleep restriction leads to increased activation of brain regions sensitive to food stimuli. Am J Clin Nutr. 2012;95(4):818–824.
   PubMed Web of Science ®Google Scholar
• Gujar N, Yoo SS, Hu P, Walker MP. Sleep deprivation amplifies reactivity of brain reward networks, biasing the appraisal of positive emotional experiences. J Neurosci. 2011;31(12):4466–4474.
   PubMed Web of Science ®Google Scholar
• van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet. 2005;8(5):450–458.
   PubMed Web of Science ®Google Scholar
• Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158(10):1568–1578.
   PubMed Web of Science ®Google Scholar
• Stewart SE, Pauls DL. The genetics of obsessive-compulsive disorder. Focus. 2010;8(3):350–357.
   Google Scholar
• Webb IC, Lehman MN, Coolen LM. Diurnal and circadian regulation of reward-related neurophysiology and behavior. Physiol Behav. 2015;143:58–69.
   PubMed Web of Science ®Google Scholar
• Forbes EE, Dahl RE, Almeida JR, et al. PER2 rs2304672 polymorphism moderates circadian-relevant reward circuitry activity in adolescents. Biol Psychiatry. 2012;71(5):451–457.
   PubMed Web of Science ®Google Scholar
• da Rocha FF, Malloy-Diniz L, Lage NV, Correa H. The relationship between the Met allele of the BDNF Val66Met polymorphism and impairments in decision making under ambiguity in patients with obsessive-compulsive disorder. Genes Brain Behav. 2011;10(5):523–529.
   Web of Science ®Google Scholar
• Vinberg M, Trajkovska V, Bennike B, Knorr U, Knudsen GM, Kessing LV. The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol. Psychoneuroendocrinology. 2009;34(9):1380–1389.
   PubMed Web of Science ®Google Scholar
• Yu H, Wang DD, Wang Y, Liu T, Lee FS, Chen ZY. Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J Neurosci. 2012;32(12):4092–4101.
   PubMed Web of Science ®Google Scholar
• Bachmann V, Klein C, Bodenmann S, et al. The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity. Sleep. 2012;35(3):335–344.
   PubMed Web of Science ®Google Scholar
• Moller-Levet CS, Archer SN, Bucca G, et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci U S A. 2013;110(12):E1132–E1141.
   PubMed Web of Science ®Google Scholar
• Archer SN, Laing EE, Moller-Levet CS, et al. Mistimed sleep disrupts circadian regulation of the human transcriptome. Proc Natl Acad Sci U S A. 2014;111(6):E682–E691.
   PubMed Web of Science ®Google Scholar
• Fineberg NA, Reghunandanan S, Simpson HB, et al. Obsessive-compulsive disorder (OCD): practical strategies for pharmacological and somatic treatment in adults. Psychiatry Res. 2015;227(1):114–125.
   PubMed Web of Science ®Google Scholar
• McKay D, Sookman D, Neziroglu F, et al. Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder. Psychiatry Res. 2015;227(1):104–113.
   Web of Science ®Google Scholar
• Stanley MA, Turnei SM. Current status of pharmacological and behavioral treatment of obsessive-compulsive disorder. Behav Ther. 1995;26:163–186.
   Web of Science ®Google Scholar
• Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008;(1):CD001765.
   Web of Science ®Google Scholar
• Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders–first revision. World J Biol Psychiatry. 2008;9(4):248–312.
   PubMed Web of Science ®Google Scholar
• Piccinelli M, Pini S, Bellantuono C, Wilkinson G. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Br J Psychiatry. 1995;166(4):424–443.
   PubMed Web of Science ®Google Scholar
• Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry. 1995;52(1):53–60.
   PubMed Web of Science ®Google Scholar
• Ackerman DL, Greenland S. Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharmacol. 2002;22(3):309–317.
   PubMed Web of Science ®Google Scholar
• Pigott TA, Seay SM. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry. 1999;60(2):101–106.
   PubMed Web of Science ®Google Scholar
• Albelda N, Joel D. Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates. Neurosci Biobehav Rev. 2012;36(1):47–63.
   PubMed Web of Science ®Google Scholar
• Lopes AC, de Mathis ME, Canteras MM, Salvajoli JV, Del Porto JA, Miguel EC. Atualização sobre o tratamento neurocirúrgico do transtorno obsessivo-compulsivo. [Update on neurosurgical treatment for obsessive compulsive disorder]. Rev Bras Psiquiatr. 2004;26(1):62–66. Portuguese.
   PubMedGoogle Scholar
• Burguiere E, Monteiro P, Mallet L, Feng G, Graybiel AM. Striatal circuits, habits, and implications for obsessive-compulsive disorder. Curr Opin Neurobiol. 2015;30:59–65.
   PubMed Web of Science ®Google Scholar
• Goodman WK, Ward HE, Murphy TK. Biologic approaches to treatment-refractory obsessive-compulsive disorder. Psychiatr Ann. 1998;28(11):641.
   Web of Science ®Google Scholar
• Paino M, Fonseca-Pedrero E, Bousoño M, Lemos-Giráldez S. Light-therapy applications for DSM-IV-TR disease entities. Eur J Psychiatry. 2009;23(3):166–176.
   Web of Science ®Google Scholar
• Brinkhuijsen M, Koenegracht F, Meesters Y. Symptoms of seasonal affective disorder and of obsessive-compulsive disorder reduced by light therapy. J Affect Disord. 2003;74(3):307–308.
   PubMed Web of Science ®Google Scholar
• Hoflich G, Kasper S, Moller HJ. Erfolgreiche Behandlung eines saisonalen Zwangssyndroms mit Lichttherapie. [Light therapy in the treatment of a seasonal form of obsessive-compulsive disorder]. Nervenarzt. 1992;63(11):701–704. German.
   PubMedGoogle Scholar
• Yoney TH, Pigott TA, L’Heureux F, Rosenthal NE. Seasonal variation in obsessive-compulsive disorder: preliminary experience with light treatment. Am J Psychiatry. 1991;148(12):1727–1729.
   Web of Science ®Google Scholar
• Partonen T, Lonnqvist J. Seasonal affective disorder. Lancet. 1998;352(9137):1369–1374.
   PubMed Web of Science ®Google Scholar
• Terman M, Lewy AJ, Dijk DJ, Boulos Z, Eastman CI, Campbell SS. Light treatment for sleep disorders: consensus report. IV. Sleep phase and duration disturbances. J Biol Rhythms. 1995;10(2):135–147.
   PubMed Web of Science ®Google Scholar
• Amir S, Robinson B, Ratovitski T, Rea MA, Stewart J, Simantov R. A role for serotonin in the circadian system revealed by the distribution of serotonin transporter and light-induced Fos immunoreactivity in the suprachiasmatic nucleus and intergeniculate leaflet. Neuroscience. 1998;84(4):1059–1073.
   Web of Science ®Google Scholar
• Klein DC, Weller JL. Rapid light-induced decrease in pineal serotonin N-acetyltransferase activity. Science. 1972;177(4048):532–533.
   Web of Science ®Google Scholar
• Cuesta M, Mendoza J, Clesse D, Pevet P, Challet E. Serotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodent. Exp Neurol. 2008;210(2):501–513.
   PubMed Web of Science ®Google Scholar
• Knoch ME, Siegel D, Duncan MJ, Glass JD. Serotonergic mediation of constant light-potentiated nonphotic phase shifting of the circadian locomotor activity rhythm in Syrian hamsters. Am J Physiol Regul Integr Comp Physiol. 2006;291(1):R180–R188.
   Web of Science ®Google Scholar
• Kaur G, Thind R, Glass JD. Brief constant light accelerates serotonergic re-entrainment to large shifts of the daily light/dark cycle. Neuroscience. 2009;159(4):1430–1440.
   Web of Science ®Google Scholar
• de Bodinat C, Guardiola-Lemaitre B, Mocaer E, Renard P, Munoz C, Millan MJ. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov. 2010;9(8):628–642.
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Moscovitch A, Srinivasan V, Spence DW, Cardinali DP, Brown GM. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine. Prog Neurobiol. 2009;88(4):264–271.
   Web of Science ®Google Scholar
• Stein DJ, Picarel-Blanchot F, Kennedy SH. Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression. Hum Psychopharmacol. 2013;28(2):151–159.
   PubMed Web of Science ®Google Scholar
• Perugi G, Quaranta G, Bucci N. The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms. Expert Opin Investig Drugs. 2015;24(5):705–713.
   PubMed Web of Science ®Google Scholar
• De Berardis D, Serroni N, Marini S, et al. Agomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder: a case report. Case Rep Psychiatry. 2012;2012:642752.
   PubMedGoogle Scholar
• da Rocha FF, Correa H. Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCD. Clin Neuropharmacol. 2011;34(4):139–140.
   PubMed Web of Science ®Google Scholar
• Signorelli MS, Concerto C, Battaglia E, Costanzo MC, Battaglia F, Aguglia E. Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors. SAGE Open Med Case Rep. 2014;2:1–3. DOI: 10.1177/2050313X14561778.
   Google Scholar
• Fornaro M. Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series. Ann Gen Psychiatry. 2011; 10(1):5.
   PubMed Web of Science ®Google Scholar
• Tzavellas E, Karaiskos D, Ilias I, Liappas I, Paparrigopoulos T. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report. Psychiatriki. 2014;25(3):179–184.
   Google Scholar
• De Berardis D, Serroni N, Campanella D, et al. A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy. J Clin Psychopharmacol. 2012;32(2):289–290.
   PubMed Web of Science ®Google Scholar
• Antoniadis D, Floros GD, Nikolaidis N, Garyfallos G. Response to agomelatine: treatment of an obsessive skin picking episode. Ann Clin Psychiatry. 2013;25(3):228–229.
   PubMed Web of Science ®Google Scholar
• Fornaro M, Prestia D, Colicchio S, Perugi G. A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. Curr Neuropharmacol. 2010;8(3):287–304.
   PubMed Web of Science ®Google Scholar
• Tardito D, Milanese M, Bonifacino T, et al. Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways. BMC Neurosci. 2010;11:68.
   PubMed Web of Science ®Google Scholar
• Weitzman ED, Czeisler CA, Coleman RM, et al. Delayed sleep phase syndrome. A chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry. 1981;38(7):737–746.
   PubMed Web of Science ®Google Scholar
• Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med. 2015;163(3):191–204.
   PubMed Web of Science ®Google Scholar
• Taylor DJ, Pruiksma KE. Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: a systematic review. Int Rev Psychiatry. 2014;26(2):205–213.
   PubMed Web of Science ®Google Scholar
• Grandin LD, Alloy LB, Abramson LY. The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation. Clin Psychol Rev. 2006;26(6):679–694.
   PubMed Web of Science ®Google Scholar
• Bouwkamp CG, de Kruiff ME, van Troost TM, et al. Interpersonal and social rhythm group therapy for patients with bipolar disorder. Int J Group Psychother. 2013;63(1):97–115.
   PubMed Web of Science ®Google Scholar
• Frank E, Kupfer DJ, Thase ME, et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry. 2005;62(9):996–1004.
   PubMed Web of Science ®Google Scholar
• Perugi G, Akiskal HS, Pfanner C, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord. 1997;46(1):15–23.
   PubMed Web of Science ®Google Scholar
• Perugi G, Toni C, Frare F, Travierso MC, Hantouche E, Akiskal HS. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry. 2002;63(12):1129–1134.
   PubMed Web of Science ®Google Scholar
• Tukel R, Meteris H, Koyuncu A, Tecer A, Yazici O. The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci. 2006;256(4):240–245.
   PubMed Web of Science ®Google Scholar
• Hantouche EG, Angst J, Demonfaucon C, Perugi G, Lancrenon S, Akiskal HS. Cyclothymic OCD: a distinct form? J Affect Disord. 2003;75(1):1–10.
   PubMed Web of Science ®Google Scholar